BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6845798)

  • 1. [Comparison of 3 corticoid preparations with the vasoconstriction and erythema test].
    Früh H
    Z Hautkr; 1983 Mar; 58(5):317-23. PubMed ID: 6845798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC; Kaminester L; Frost P
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of urea in a topical corticoid preparation on vasoconstriction].
    Früh H
    Z Hautkr; 1983 Aug; 58(16):1203-5. PubMed ID: 6624181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
    Woodford R
    Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
    [No Abstract]   [Full Text] [Related]  

  • 6. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of diflucortolone valerate in the vasoconstriction tests].
    Wendt VH; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1495-8. PubMed ID: 1036946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis: treatment with a new topical corticosteroid.
    Kanof NB; Blau S
    Cutis; 1976 Apr; 17(4):796-8. PubMed ID: 797543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of halcinonide and betamethasone valerate in common dermatoses.
    Turnbull BC
    Australas J Dermatol; 1975 Apr; 16(1):17-9. PubMed ID: 1108858
    [No Abstract]   [Full Text] [Related]  

  • 12. Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects.
    Haapasaari KM; Risteli J; Oikarinen A
    Br J Dermatol; 1996 Jul; 135(1):65-9. PubMed ID: 8776361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: a pilot randomized study of humans.
    Maruani A; Boucaud A; Perrodeau E; Gendre D; Giraudeau B; Machet L
    Int J Pharm; 2010 Aug; 395(1-2):84-90. PubMed ID: 20472045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
    Wiedersberg S; Naik A; Leopold CS; Guy RH
    Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of glycosuria and hyperglycemia by topical corticosteroid therapy.
    Gomez EC; Frost P
    Arch Dermatol; 1976 Nov; 112(11):1559-62. PubMed ID: 984862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of topical steroid application on tuberculin skin reactions in healthy persons.
    Thestrup-Pedersen K; Ahlburg H; Hansen P; Larsen PO
    Acta Derm Venereol; 1982; 62(1):43-6. PubMed ID: 6175136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of betamethasone valerate on the normal human facial skin flora.
    Daltrey DC; Cunliffe WJ
    Acta Derm Venereol; 1983; 63(2):160-2. PubMed ID: 6189335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
    Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
    Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis.
    Weiss SC; Nguyen J; Chon S; Kimball AB
    J Drugs Dermatol; 2005; 4(3):339-45. PubMed ID: 15898290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.